PubMed Health⌕ Search

Biomedical subjects

John R Stroehlein

Publications and source records attributed to John R Stroehlein.

2 recordsLinked to original sources

Adenocarcinoma of the small bowel: a 60-yr perspective derived from M. D. Anderson Cancer Center Tumor Registry.

OBJECTIVES: To analyze subsite distribution of small bowel adenocarcinoma (SBA) over a 60-yr interval and to determine the impact of age, gender, and ethnicity on SBA cross-referenced for selected variables including anatomic distribution. METHODS: Data from 1944 to 2003 were extracted from the M. D. Anderson Cancer Center Tumor Registry (MDACCTR) and analyzed by age, gender, ethnicity, anatomic site, and time intervals. RESULTS: A total of 523 confirmed cases with 460 specified for subsite were identified. Peak incidence occurred in the sixth decade with male predominance (58%). Relative distribution for subsites was stable over the period of study; however, site-specific incidence differed significantly with age. Although jejunal SBA comprised only 21% of site-specific total (SST), 49% occurred in 0-49 age group rendering duodenal SBA (59% of SST) more common with increasing age (p < 0.001). A higher percentage of women presented at younger age; however, the difference was not significant (p = 0.061). Subsite distribution was similar for both genders, but varied significantly among ethnicities (p = 0.048) with Hispanics and African Americans having a higher percentage of duodenal SBA. The age and gender distribution among ethnicities varied significantly. African Americans having SBA presented at a younger age (p < 0.001), and comprised a higher percentage of women (p = 0.026). CONCLUSION: Differences exist for SBA subsite distribution within age and ethnic groups but not gender. Unlike colon cancer, SBA subsite distribution has been stable during the last six decades. Different risk factors for SBA appear to affect different subsites. Site- and age-related distribution impacts on diagnostic evaluation for SBA.

Adenocarcinoma↗

Microscopic colitis.

Microscopic colitis is a condition that is clinically underrecognized as a cause of chronic or intermittent diarrhea and can be diagnosed only by mucosal biopsy. Microscopic colitis is more common in middle-age to elderly women, appears to be induced by some medications, particularly nonsteroidal antiinflammatory drugs, and has been associated with autoimmune conditions and sprue. Symptomatic treatment includes cholestyramine and antidiarrheal medications. Bismuth subsalicylate, and 5-amniosalicylates are therapeutic options; however, budesonide is more effective in achieving clinical and histologic improvement and/or remission and has been studied in more randomized trials. Use of immune modulators should be restricted to more severe cases that are steroid refractory or steroid dependent. Surgical intervention should be reserved for a very highly select group of refractory cases. Diverting ileostomy or colectomy appear to be equally effective surgical alternatives for microscopic colitis, which is not a risk factor for carcinoma.

Journal Article↗